Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parkinson’s Disease Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Transdermal
1.2.4 Subcutaneous
1.2.5 Intestinal Infusion
1.3 Market by Application
1.3.1 Global Parkinson’s Disease Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Parkinson’s Disease Therapeutics Market Perspective (2018-2029)
2.2 Parkinson’s Disease Therapeutics Growth Trends by Region
2.2.1 Global Parkinson’s Disease Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Parkinson’s Disease Therapeutics Historic Market Size by Region (2018-2024)
2.2.3 Parkinson’s Disease Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 Parkinson’s Disease Therapeutics Market Dynamics
2.3.1 Parkinson’s Disease Therapeutics Industry Trends
2.3.2 Parkinson’s Disease Therapeutics Market Drivers
2.3.3 Parkinson’s Disease Therapeutics Market Challenges
2.3.4 Parkinson’s Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Parkinson’s Disease Therapeutics Players by Revenue
3.1.1 Global Top Parkinson’s Disease Therapeutics Players by Revenue (2018-2024)
3.1.2 Global Parkinson’s Disease Therapeutics Revenue Market Share by Players (2018-2024)
3.2 Global Parkinson’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Parkinson’s Disease Therapeutics Revenue
3.4 Global Parkinson’s Disease Therapeutics Market Concentration Ratio
3.4.1 Global Parkinson’s Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parkinson’s Disease Therapeutics Revenue in 2022
3.5 Parkinson’s Disease Therapeutics Key Players Head office and Area Served
3.6 Key Players Parkinson’s Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Parkinson’s Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Parkinson’s Disease Therapeutics Breakdown Data by Type
4.1 Global Parkinson’s Disease Therapeutics Historic Market Size by Type (2018-2024)
4.2 Global Parkinson’s Disease Therapeutics Forecasted Market Size by Type (2024-2029)
5 Parkinson’s Disease Therapeutics Breakdown Data by Application
5.1 Global Parkinson’s Disease Therapeutics Historic Market Size by Application (2018-2024)
5.2 Global Parkinson’s Disease Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Parkinson’s Disease Therapeutics Market Size (2018-2029)
6.2 North America Parkinson’s Disease Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Parkinson’s Disease Therapeutics Market Size by Country (2018-2024)
6.4 North America Parkinson’s Disease Therapeutics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Parkinson’s Disease Therapeutics Market Size (2018-2029)
7.2 Europe Parkinson’s Disease Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Parkinson’s Disease Therapeutics Market Size by Country (2018-2024)
7.4 Europe Parkinson’s Disease Therapeutics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Parkinson’s Disease Therapeutics Market Size (2018-2029)
8.2 Asia-Pacific Parkinson’s Disease Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Region (2018-2024)
8.4 Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Parkinson’s Disease Therapeutics Market Size (2018-2029)
9.2 Latin America Parkinson’s Disease Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Parkinson’s Disease Therapeutics Market Size by Country (2018-2024)
9.4 Latin America Parkinson’s Disease Therapeutics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Parkinson’s Disease Therapeutics Market Size (2018-2029)
10.2 Middle East & Africa Parkinson’s Disease Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Country (2018-2024)
10.4 Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbvie
11.1.1 Abbvie Company Detail
11.1.2 Abbvie Business Overview
11.1.3 Abbvie Parkinson’s Disease Therapeutics Introduction
11.1.4 Abbvie Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.1.5 Abbvie Recent Development
11.2 Biogen
11.2.1 Biogen Company Detail
11.2.2 Biogen Business Overview
11.2.3 Biogen Parkinson’s Disease Therapeutics Introduction
11.2.4 Biogen Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.2.5 Biogen Recent Development
11.3 Boehringer Ingelheim GmbH
11.3.1 Boehringer Ingelheim GmbH Company Detail
11.3.2 Boehringer Ingelheim GmbH Business Overview
11.3.3 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Introduction
11.3.4 Boehringer Ingelheim GmbH Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.3.5 Boehringer Ingelheim GmbH Recent Development
11.4 F. Hoffman-La Roche
11.4.1 F. Hoffman-La Roche Company Detail
11.4.2 F. Hoffman-La Roche Business Overview
11.4.3 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Introduction
11.4.4 F. Hoffman-La Roche Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.4.5 F. Hoffman-La Roche Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Parkinson’s Disease Therapeutics Introduction
11.5.4 GlaxoSmithKline Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.5.5 GlaxoSmithKline Recent Development
11.6 H. Lundbeck A/S
11.6.1 H. Lundbeck A/S Company Detail
11.6.2 H. Lundbeck A/S Business Overview
11.6.3 H. Lundbeck A/S Parkinson’s Disease Therapeutics Introduction
11.6.4 H. Lundbeck A/S Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.6.5 H. Lundbeck A/S Recent Development
11.7 Impax Labs
11.7.1 Impax Labs Company Detail
11.7.2 Impax Labs Business Overview
11.7.3 Impax Labs Parkinson’s Disease Therapeutics Introduction
11.7.4 Impax Labs Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.7.5 Impax Labs Recent Development
11.8 Newron Pharmaceuticals SpA
11.8.1 Newron Pharmaceuticals SpA Company Detail
11.8.2 Newron Pharmaceuticals SpA Business Overview
11.8.3 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Introduction
11.8.4 Newron Pharmaceuticals SpA Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.8.5 Newron Pharmaceuticals SpA Recent Development
11.9 Novartis AG
11.9.1 Novartis AG Company Detail
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Parkinson’s Disease Therapeutics Introduction
11.9.4 Novartis AG Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.9.5 Novartis AG Recent Development
11.10 Orion Corporation
11.10.1 Orion Corporation Company Detail
11.10.2 Orion Corporation Business Overview
11.10.3 Orion Corporation Parkinson’s Disease Therapeutics Introduction
11.10.4 Orion Corporation Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.10.5 Orion Corporation Recent Development
11.11 Teva Pharmaceutical Industries Ltd.
11.11.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.11.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.11.3 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Introduction
11.11.4 Teva Pharmaceutical Industries Ltd. Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.11.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.12 UCB S.A.
11.12.1 UCB S.A. Company Detail
11.12.2 UCB S.A. Business Overview
11.12.3 UCB S.A. Parkinson’s Disease Therapeutics Introduction
11.12.4 UCB S.A. Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.12.5 UCB S.A. Recent Development
11.13 Livzon Pharmaceutical
11.13.1 Livzon Pharmaceutical Company Detail
11.13.2 Livzon Pharmaceutical Business Overview
11.13.3 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Introduction
11.13.4 Livzon Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.13.5 Livzon Pharmaceutical Recent Development
11.14 Haisco Pharmaceutical
11.14.1 Haisco Pharmaceutical Company Detail
11.14.2 Haisco Pharmaceutical Business Overview
11.14.3 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Introduction
11.14.4 Haisco Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.14.5 Haisco Pharmaceutical Recent Development
11.15 Jingxin Pharmaceutical
11.15.1 Jingxin Pharmaceutical Company Detail
11.15.2 Jingxin Pharmaceutical Business Overview
11.15.3 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Introduction
11.15.4 Jingxin Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.15.5 Jingxin Pharmaceutical Recent Development
11.16 Dongcheng Biochemicals
11.16.1 Dongcheng Biochemicals Company Detail
11.16.2 Dongcheng Biochemicals Business Overview
11.16.3 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Introduction
11.16.4 Dongcheng Biochemicals Revenue in Parkinson’s Disease Therapeutics Business (2018-2024)
11.16.5 Dongcheng Biochemicals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Parkinson’s Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Oral
Table 3. Key Players of Transdermal
Table 4. Key Players of Subcutaneous
Table 5. Key Players of Intestinal Infusion
Table 6. Global Parkinson’s Disease Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Parkinson’s Disease Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Parkinson’s Disease Therapeutics Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Parkinson’s Disease Therapeutics Market Share by Region (2018-2024)
Table 10. Global Parkinson’s Disease Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Parkinson’s Disease Therapeutics Market Share by Region (2024-2029)
Table 12. Parkinson’s Disease Therapeutics Market Trends
Table 13. Parkinson’s Disease Therapeutics Market Drivers
Table 14. Parkinson’s Disease Therapeutics Market Challenges
Table 15. Parkinson’s Disease Therapeutics Market Restraints
Table 16. Global Parkinson’s Disease Therapeutics Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Parkinson’s Disease Therapeutics Market Share by Players (2018-2024)
Table 18. Global Top Parkinson’s Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson’s Disease Therapeutics as of 2022)
Table 19. Ranking of Global Top Parkinson’s Disease Therapeutics Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Parkinson’s Disease Therapeutics Revenue (CR5 and HHI) & (2018-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Parkinson’s Disease Therapeutics Product Solution and Service
Table 23. Date of Enter into Parkinson’s Disease Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Parkinson’s Disease Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Parkinson’s Disease Therapeutics Revenue Market Share by Type (2018-2024)
Table 27. Global Parkinson’s Disease Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Parkinson’s Disease Therapeutics Revenue Market Share by Type (2024-2029)
Table 29. Global Parkinson’s Disease Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Parkinson’s Disease Therapeutics Revenue Market Share by Application (2018-2024)
Table 31. Global Parkinson’s Disease Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Parkinson’s Disease Therapeutics Revenue Market Share by Application (2024-2029)
Table 33. North America Parkinson’s Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Parkinson’s Disease Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 35. North America Parkinson’s Disease Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Parkinson’s Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Parkinson’s Disease Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 38. Europe Parkinson’s Disease Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Parkinson’s Disease Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Region (2018-2024) & (US$ Million)
Table 41. Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Parkinson’s Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Parkinson’s Disease Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 44. Latin America Parkinson’s Disease Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Parkinson’s Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 47. Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 48. Abbvie Company Detail
Table 49. Abbvie Business Overview
Table 50. Abbvie Parkinson’s Disease Therapeutics Product
Table 51. Abbvie Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 52. Abbvie Recent Development
Table 53. Biogen Company Detail
Table 54. Biogen Business Overview
Table 55. Biogen Parkinson’s Disease Therapeutics Product
Table 56. Biogen Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 57. Biogen Recent Development
Table 58. Boehringer Ingelheim GmbH Company Detail
Table 59. Boehringer Ingelheim GmbH Business Overview
Table 60. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product
Table 61. Boehringer Ingelheim GmbH Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 62. Boehringer Ingelheim GmbH Recent Development
Table 63. F. Hoffman-La Roche Company Detail
Table 64. F. Hoffman-La Roche Business Overview
Table 65. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product
Table 66. F. Hoffman-La Roche Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 67. F. Hoffman-La Roche Recent Development
Table 68. GlaxoSmithKline Company Detail
Table 69. GlaxoSmithKline Business Overview
Table 70. GlaxoSmithKline Parkinson’s Disease Therapeutics Product
Table 71. GlaxoSmithKline Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 72. GlaxoSmithKline Recent Development
Table 73. H. Lundbeck A/S Company Detail
Table 74. H. Lundbeck A/S Business Overview
Table 75. H. Lundbeck A/S Parkinson’s Disease Therapeutics Product
Table 76. H. Lundbeck A/S Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 77. H. Lundbeck A/S Recent Development
Table 78. Impax Labs Company Detail
Table 79. Impax Labs Business Overview
Table 80. Impax Labs Parkinson’s Disease Therapeutics Product
Table 81. Impax Labs Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 82. Impax Labs Recent Development
Table 83. Newron Pharmaceuticals SpA Company Detail
Table 84. Newron Pharmaceuticals SpA Business Overview
Table 85. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product
Table 86. Newron Pharmaceuticals SpA Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 87. Newron Pharmaceuticals SpA Recent Development
Table 88. Novartis AG Company Detail
Table 89. Novartis AG Business Overview
Table 90. Novartis AG Parkinson’s Disease Therapeutics Product
Table 91. Novartis AG Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 92. Novartis AG Recent Development
Table 93. Orion Corporation Company Detail
Table 94. Orion Corporation Business Overview
Table 95. Orion Corporation Parkinson’s Disease Therapeutics Product
Table 96. Orion Corporation Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 97. Orion Corporation Recent Development
Table 98. Teva Pharmaceutical Industries Ltd. Company Detail
Table 99. Teva Pharmaceutical Industries Ltd. Business Overview
Table 100. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product
Table 101. Teva Pharmaceutical Industries Ltd. Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 102. Teva Pharmaceutical Industries Ltd. Recent Development
Table 103. UCB S.A. Company Detail
Table 104. UCB S.A. Business Overview
Table 105. UCB S.A. Parkinson’s Disease Therapeutics Product
Table 106. UCB S.A. Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 107. UCB S.A. Recent Development
Table 108. Livzon Pharmaceutical Company Detail
Table 109. Livzon Pharmaceutical Business Overview
Table 110. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product
Table 111. Livzon Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 112. Livzon Pharmaceutical Recent Development
Table 113. Haisco Pharmaceutical Company Detail
Table 114. Haisco Pharmaceutical Business Overview
Table 115. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product
Table 116. Haisco Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 117. Haisco Pharmaceutical Recent Development
Table 118. Jingxin Pharmaceutical Company Detail
Table 119. Jingxin Pharmaceutical Business Overview
Table 120. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product
Table 121. Jingxin Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 122. Jingxin Pharmaceutical Recent Development
Table 123. Dongcheng Biochemicals Company Detail
Table 124. Dongcheng Biochemicals Business Overview
Table 125. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product
Table 126. Dongcheng Biochemicals Revenue in Parkinson’s Disease Therapeutics Business (2018-2024) & (US$ Million)
Table 127. Dongcheng Biochemicals Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Parkinson’s Disease Therapeutics Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Parkinson’s Disease Therapeutics Market Share by Type: 2022 VS 2029
Figure 3. Oral Features
Figure 4. Transdermal Features
Figure 5. Subcutaneous Features
Figure 6. Intestinal Infusion Features
Figure 7. Global Parkinson’s Disease Therapeutics Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 8. Global Parkinson’s Disease Therapeutics Market Share by Application: 2022 VS 2029
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Parkinson’s Disease Therapeutics Report Years Considered
Figure 13. Global Parkinson’s Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Parkinson’s Disease Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Parkinson’s Disease Therapeutics Market Share by Region: 2022 VS 2029
Figure 16. Global Parkinson’s Disease Therapeutics Market Share by Players in 2022
Figure 17. Global Top Parkinson’s Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson’s Disease Therapeutics as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Parkinson’s Disease Therapeutics Revenue in 2022
Figure 19. North America Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Parkinson’s Disease Therapeutics Market Share by Country (2018-2029)
Figure 21. United States Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Parkinson’s Disease Therapeutics Market Share by Country (2018-2029)
Figure 25. Germany Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Parkinson’s Disease Therapeutics Market Share by Region (2018-2029)
Figure 33. China Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Parkinson’s Disease Therapeutics Market Share by Country (2018-2029)
Figure 41. Mexico Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Parkinson’s Disease Therapeutics Market Share by Country (2018-2029)
Figure 45. Turkey Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Parkinson’s Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Abbvie Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 48. Biogen Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 49. Boehringer Ingelheim GmbH Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 50. F. Hoffman-La Roche Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 51. GlaxoSmithKline Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 52. H. Lundbeck A/S Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 53. Impax Labs Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 54. Newron Pharmaceuticals SpA Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 55. Novartis AG Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 56. Orion Corporation Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 57. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 58. UCB S.A. Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 59. Livzon Pharmaceutical Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 60. Haisco Pharmaceutical Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 61. Jingxin Pharmaceutical Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 62. Dongcheng Biochemicals Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2018-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed